23843-64-3

Usage

Uses

Used in Catalyst Support Industry:
1-[3-(Trimethoxysilyl)propyl]urea is used as a catalyst support for immobilizing surface enzymes and nanoparticles on 1-[3-(Trimethoxysilyl)propyl]urea capped magnetic nanoparticles. This application enhances the stability and reusability of the catalysts, making them more efficient in various chemical reactions.
Used in Medical Applications:
In the medical field, 1-[3-(Trimethoxysilyl)propyl]urea is used for the silanization of ceria, a compound with potential applications as a medical agent. The silanization process improves the biocompatibility and performance of ceria, making it suitable for use in various medical treatments and diagnostics.

InChI:InChI=1/C7H18N2O4Si/c1-11-14(12-2,13-3)6-4-5-9-7(8)10/h4-6H2,1-3H3,(H3,8,9,10)

Upstream product

• 13822-56-5 3-(trimethoxysilyl)propan-1-amine 
• 57-13-6 urea 

Relevant academic research and scientific papers

METHOD FOR PRODUCING UREIDO GROUP-CONTAINING ORGANOSILICON COMPOUND

A method for producing an ureido group-containing organosilicon compound includes the following steps (I) and (II): (I): a step of obtaining a compound represented by formula (1) by reacting urea and an amino group-containing organosilicon compound represented by formula (3): wherein R1 represents an alkyl group having 1 to 10 carbon atoms or the like, R3 represents a hydrogen atom or the like, Me represents a methyl group, m represents an integer of 1 to 3, and n represents an integer of 1 to 12, wherein R2 represents a hydrogen atom or the like, and R1, Me, m, and n represent the same meaning as described above; and (II): a step of further reacting by supplying the amino group-containing organosilicon compound represented by formula (3) to a mixture containing a compound represented by formula (1) and urea.

Process for manufacturing polysiloxane microcapsules that are functionalized and are not very porous

A method is provided for encapsulating products that can have lipophilic or hydrophilic, including volatile, properties in a polysiloxane membrane that is particularly impervious. A method is also provided for evaluating the imperviousness of capsules. The present method includes the following steps: a) formation of droplets by an emulsion between an oily phase containing the product to be encapsulated and an acidic aqueous phase heated to around 50° C. and in the presence of surfactants; b) addition and hydrolysis of at least one silane in order to obtain a silanol; c) increasing the pH in order to start condensation of the silanol to form a first membrane around the droplets of the product to be encapsulated; d) lowering the pH; e) increasing the pH, optionally preceded by adding a silane, in order to obtain a new condensation of silanol around the droplets of the product to be encapsulated.